GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Toho Holdings Co Ltd (TSE:8129) » Definitions » EV-to-EBIT

Toho Holdings Co (TSE:8129) EV-to-EBIT : 4.44 (As of May. 17, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Toho Holdings Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Toho Holdings Co's Enterprise Value is 円136,970 Mil. Toho Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円30,845 Mil. Therefore, Toho Holdings Co's EV-to-EBIT for today is 4.44.

The historical rank and industry rank for Toho Holdings Co's EV-to-EBIT or its related term are showing as below:

TSE:8129' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.11   Med: 6.76   Max: 11.26
Current: 4.45

During the past 13 years, the highest EV-to-EBIT of Toho Holdings Co was 11.26. The lowest was 3.11. And the median was 6.76.

TSE:8129's EV-to-EBIT is ranked better than
86.25% of 80 companies
in the Medical Distribution industry
Industry Median: 13.74 vs TSE:8129: 4.45

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Toho Holdings Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円112,431 Mil. Toho Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円30,845 Mil. Toho Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 27.43%.


Toho Holdings Co EV-to-EBIT Historical Data

The historical data trend for Toho Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toho Holdings Co EV-to-EBIT Chart

Toho Holdings Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.96 9.08 3.82 5.33 4.08

Toho Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 5.82 3.87 4.27 -

Competitive Comparison of Toho Holdings Co's EV-to-EBIT

For the Medical Distribution subindustry, Toho Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Toho Holdings Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Toho Holdings Co's EV-to-EBIT falls into.



Toho Holdings Co EV-to-EBIT Calculation

Toho Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=136969.903/30845
=4.44

Toho Holdings Co's current Enterprise Value is 円136,970 Mil.
Toho Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円30,845 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Toho Holdings Co  (TSE:8129) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Toho Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=30845/112431.3592
=27.43 %

Toho Holdings Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円112,431 Mil.
Toho Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円30,845 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Toho Holdings Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Toho Holdings Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Toho Holdings Co (TSE:8129) Business Description

Traded in Other Exchanges
N/A
Address
5-2-1, Daizawa, Setagaya-ku, Tokyo, JPN, 155-8655
Toho Holdings Co., Ltd. is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. Toho also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. Toho generates additional revenue through software sales to medical institutions.

Toho Holdings Co (TSE:8129) Headlines

No Headlines